Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.

Koido, Shigeo et al.·Journal for immunotherapy of cancer·2025·
RPEP-118872025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.
Published In:
Journal for immunotherapy of cancer, 13(7) (2025)
Database ID:
RPEP-11887

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11887·https://rethinkpeptides.com/research/RPEP-11887

APA

Koido, Shigeo; Taguchi, Junichi; Shimabuku, Masamori; Bito, Tuuse; Morimoto, Soyoko; Oji, Yusuke; Oka, Yoshihiro; Ito, Masaki; Shimizu, Yoko; Ito, Zensho; Uchiyama, Kan; Saruta, Masayuki; Sato, Nobuhiro; Ohkusa, Toshifumi; Shimodaira, Shigetaka; Sugiyama, Haruo. (2025). Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.. Journal for immunotherapy of cancer, 13(7). https://doi.org/10.1136/jitc-2024-011426

MLA

Koido, Shigeo, et al. "Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.." Journal for immunotherapy of cancer, 2025. https://doi.org/10.1136/jitc-2024-011426

RethinkPeptides

RethinkPeptides Research Database. "Predictors of patients with advanced pancreatic cancer under..." RPEP-11887. Retrieved from https://rethinkpeptides.com/research/koido-2025-predictors-of-patients-with

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.